📍 HANOI, VIETNAM
01.11.2026
FDA Confronts Administrative Complexities in Bid to Revoke Tavneos Drug Approval
The United States Food and Drug Administration is confronting substantial legal and procedural hurdles as it moves to rescind its regulatory approval for the autoimmune drug Tavneos. The federal agency initiated revocati...